Sold Out

Preliminary clinical evaluation in MRI: Part 1

10th October 2020  09:30 AM - 13:30 (GMT+00:00) GMT

Virtual event – Saturday 10 October 
4 CPD points


Preliminary clinical evaluation in MRI: Part 1 - Saturday 10 October 
Preliminary clinical evaluation in MRI: Part 2 - Saturday 24 October 
If you wish to attend both parts of the event, you will need to register separately for each.

Due to the remote nature of many static departments and the mobile service, many MRI radiographers rarely see a radiologist or gain feedback on scans and reports. This two part, virtual event aimed at radiographers, offers an overview of interpreting MR images of the spine (part 1) and brain (part 2). It provides a review of normal and abnormal appearances that will help radiographers ensure that they are providing the necessary images for the radiologists and correct demonstration of the area. The events will also cover how to identify red flag symptoms, manage urgent findings and when to escalate.

This event is sponsored by InHealth and is run in association with Canterbury Christ Church University College.

View full virtual event programme


Educational aims:

  • To understand the clinical indications for MR of the spine and brain, including the red flag symptoms to look for and the appearances to escalate
  • To understand the rationale for the choice of pulse sequence when imaging spine and brain
  • To recognise key anatomy and common pathologies seen in the spine and brain
  • To become familiar with the terminology used in preliminary clinical evaluation of images


Joining the meeting 
The meeting room will open on Saturday 10 October from 08:30. 

Registration
Registration for this event will close at 5pm Thursday 10 September.


Registration fees:
Non member £125
BIR Members £80
InHealth employees £60*
*For this special rate please register your interest with InHealth directly

*VAT will be added at checkout, where applicable

Venue

Speakers

Sponsors

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France,Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit https://www.siemens-healthineers.com/en-uk/